Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J VAN BREEMEN

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Inherited Metabolic Disease|March 4, 2009
Different dose-dependent correction of MIP-1beta and chitotriosidase during initial enzyme replacement therapyM J van Breemen, M de Fost, M Maas, et al.
Journal of Inherited Metabolic Disease|January 9, 2007
The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levelsA C Vedder, G E Linthorst, M J van Breemen, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 25, 2009
Proteomic profiling of plasma and serum in elderly patients with deliriumBarbara C van Munster, Marielle J van Breemen, Perry D Moerland, et al.
Blood|September 13, 2003
Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic interventionRolf G Boot, Marri Verhoek, Maaike de Fost, et al.
Expert Review of Proteomics|August 18, 2009
Gaucher disease: a model disorder for biomarker discoveryRolf G Boot, Mariëlle J van Breemen, Wouter Wegdam, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 28, 2008
Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher diseaseJohannes M Aerts, Marielle J van Breemen, Anton P Bussink, et al.
Blood|August 27, 2011
Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic responseNick Dekker, Laura van Dussen, Carla E M Hollak, et al.
EMBO Molecular Medicine|July 12, 2017
A single mutation in Taiwanese H6N1 influenza hemagglutinin switches binding to human-type receptorsRobert P de Vries, Netanel Tzarum, Wenjie Peng, et al.
Plos Pathogens|June 16, 2017
Three mutations switch H7N9 influenza to human-type receptor specificityRobert P de Vries, Wenjie Peng, Oliver C Grant, et al.
Plos Pathogens|December 11, 2024
Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progressionMarloes Grobben, Margreet Bakker, Angela I Schriek, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Inherited Metabolic Disease|March 4, 2009
Different dose-dependent correction of MIP-1beta and chitotriosidase during initial enzyme replacement therapyM J van Breemen, M de Fost, M Maas, et al.
Journal of Inherited Metabolic Disease|January 9, 2007
The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levelsA C Vedder, G E Linthorst, M J van Breemen, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 25, 2009
Proteomic profiling of plasma and serum in elderly patients with deliriumBarbara C van Munster, Marielle J van Breemen, Perry D Moerland, et al.
Blood|September 13, 2003
Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic interventionRolf G Boot, Marri Verhoek, Maaike de Fost, et al.
Expert Review of Proteomics|August 18, 2009
Gaucher disease: a model disorder for biomarker discoveryRolf G Boot, Mariëlle J van Breemen, Wouter Wegdam, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 28, 2008
Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher diseaseJohannes M Aerts, Marielle J van Breemen, Anton P Bussink, et al.
Blood|August 27, 2011
Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic responseNick Dekker, Laura van Dussen, Carla E M Hollak, et al.
EMBO Molecular Medicine|July 12, 2017
A single mutation in Taiwanese H6N1 influenza hemagglutinin switches binding to human-type receptorsRobert P de Vries, Netanel Tzarum, Wenjie Peng, et al.
Plos Pathogens|June 16, 2017
Three mutations switch H7N9 influenza to human-type receptor specificityRobert P de Vries, Wenjie Peng, Oliver C Grant, et al.
Plos Pathogens|December 11, 2024
Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progressionMarloes Grobben, Margreet Bakker, Angela I Schriek, et al.
Pageof 3